Exelixis Access Services (EASE) includes programs designed to support patients who are prescribed Exelixis oncology drugs Cabometyx or Cometriq (Table).
The EASE programs are drug-specific and provide financial, access, and reimbursement support for eligible patients.
The 15-Day Free Trial Program provides free drug to help patients start Cabometyx treatment quickly.
To request this program only, complete the 15-day Free Trial Request Form.
The Quick Start Program provides free drug to eligible patients who experience a payer decision delay of 5 days or more.
The Dose Exchange program provides a free 15-tablet supply of Cabometyx in the lower dose to help patients who require a dose reduction.
Eligible patients with commercial insurance will pay $0 per month for Cabometyx or Cometriq, for a maximum benefit of $25,000 per year.
Eligible patients who are uninsured or are insured but cannot afford the cost of the medication may receive Cabometyx or Cometriq free of charge.
Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?
Help us fix it! Report broken links here.
Report Broken Links
Submit